 |
296 Diseases |  |
92 Trials |
|
92 Trials |  |
3449 News |  |
| «12...37383940414243444546474849 |
- pioglitazone / Generic mfg.
Trial completion: Does Pioglitazone Increase the Production of 15-EPI-Lipoxin A4? (clinicaltrials.gov) - Mar 8, 2012
P4, N=25, Completed, Sponsor: Baylor College of Medicine
Not yet recruiting --> Completed
- pioglitazone / Generic mfg.
Enrollment closed: Insulin Action in Individuals With Type 2 Diabetes by Natural Fatty Acids or the Medication Pioglitazone (clinicaltrials.gov) - Mar 6, 2012
P=N/A, N=0, Active, not recruiting, Sponsor: Albert Einstein College of Medicine of Yeshiva University
Not yet recruiting --> Completed Recruiting --> Active, not recruiting
- pioglitazone / Generic mfg.
Enrollment change: PEGLIST C: Pioglitazone vs. Placebo in Association With Pegylated Interferon and Ribavirin in HCV Patients With Insulin Resistance (clinicaltrials.gov) - Feb 19, 2012
P3, N=40, Active, not recruiting, Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
Recruiting --> Active, not recruiting N=90 --> 40
- | atorvastatin / Generic mfg., pioglitazone / Generic mfg.
Enrollment change: ARREST PAD (Peripheral Arterial Disease) (clinicaltrials.gov) - Feb 14, 2012
P2/3, N=113, Completed, Sponsor: Brigham and Women's Hospital
N=90 --> 40 N=200 --> 113
- | atorvastatin / Generic mfg., pioglitazone / Generic mfg.
Trial completion: ARREST PAD (Peripheral Arterial Disease) (clinicaltrials.gov) - Feb 14, 2012
P2/3, N=113, Completed, Sponsor: Brigham and Women's Hospital
N=200 --> 113 Active, not recruiting --> Completed
- pioglitazone / Generic mfg.
Trial termination, Surgery: Pioglitazone to Treat Adults Undergoing Surgery for Non-small Cell Lung Cancer (clinicaltrials.gov) - Feb 13, 2012
P2, N=1, Terminated, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Completed --> Terminated; Study never published; terminated early due to low accrual.
- Pegasys (pegylated interferon ? -2a) / Roche
Trial completion: Efficacy of Actos Lipitor Pegasys & Ribavirin in CHC GT 1 Patients Who Relapsed or Nonresponded to Peg/Riba (clinicaltrials.gov) - Feb 12, 2012
P4, N=20, Completed, Sponsor: Brooke Army Medical Center
Completed --> Terminated; Study never published; terminated early due to low accrual. Enrolling by invitation --> Completed
- | metformin / Generic mfg., pioglitazone / Generic mfg.
Trial completion: Effect of Insulin Sensitizer Therapy on Atherothrombotic and Inflammatory Profiles Associated With Insulin Resistance (clinicaltrials.gov) - Jan 24, 2012
P2, N=28, Completed, Sponsor: Mayo Clinic
Enrolling by invitation --> Completed Recruiting --> Completed
- pioglitazone / Generic mfg.
New P1 trial: Pioglitazone to Treat Opioid Withdrawal Symptoms (clinicaltrials.gov) - Jan 23, 2012
P1, N=120, Recruiting, Sponsor: National Institute on Drug Abuse (NIDA)
- pioglitazone / Generic mfg.
Trial completion: Pioglitazone Before Peginterferon and Ribavirin for Hepatitis C Infection in HIV/HCV-Coinfected Patients With Insulin Resistance (clinicaltrials.gov) - Jan 18, 2012
P2, N=19, Completed, Sponsor: AIDS Clinical Trials Group
Recruiting --> Completed Active, not recruiting --> Completed
- pioglitazone / Generic mfg.
Enrollment change: Pioglitazone as an Adjunct for Moderate to Severe Depressive Disorder (clinicaltrials.gov) - Jan 3, 2012
P2/3, N=50, Completed, Sponsor: Tehran University of Medical Sciences
Active, not recruiting --> Completed N=40 --> 50
- pioglitazone / Generic mfg.
Trial completion: Pioglitazone as an Adjunct for Moderate to Severe Depressive Disorder (clinicaltrials.gov) - Jan 3, 2012
P2/3, N=50, Completed, Sponsor: Tehran University of Medical Sciences
N=40 --> 50 Recruiting --> Completed
- | pioglitazone / Generic mfg.
Trial completion: Pioglitazone for the Treatment of Major Depressive Disorder Comorbid With Metabolic Syndrome (clinicaltrials.gov) - Dec 12, 2011
P2, N=40, Completed, Sponsor: University Hospital Case Medical Center
Recruiting --> Completed Active, not recruiting --> Completed
- rosiglitazone / Generic mfg.
Enrollment change: Thiazolidinedione Intervention With Vitamin D Evaluation (clinicaltrials.gov) - Dec 11, 2011
P4, N=1332, Terminated, Sponsor: GlaxoSmithKline
Active, not recruiting --> Completed N=16000 --> 1332
- vildagliptin / Generic mfg., pioglitazone / Generic mfg.
Trial completion: GCPD: Glucose Control in Pre-Diabetic Renal Transplant Patients (clinicaltrials.gov) - Dec 1, 2011
P2, N=51, Completed, Sponsor: Marcus Saemann
N=16000 --> 1332 Recruiting --> Completed
- | Traficet-EN (vercirnon) / Amgen
New P1 trial: A Study to Investigate the Effect of GSK1605786 on Hepatic Cytochrome P450, and BCRP and OATP1B1 Transport in Healthy Adult Subjects (clinicaltrials.gov) - Nov 30, 2011
P1, N=24, Completed, Sponsor: GlaxoSmithKline
- pioglitazone / Generic mfg.
Enrollment closed: Study the Relationship Between Obesity and Hepatitis C Replication (clinicaltrials.gov) - Nov 22, 2011
P2, N=40, Active, not recruiting, Sponsor: University of California, San Diego
Recruiting --> Completed Recruiting --> Active, not recruiting
- pioglitazone / Generic mfg.
Enrollment change: Pioglitazone Hydrochloride (Actos(Registered Trademark)) to Treat Asthma (clinicaltrials.gov) - Nov 15, 2011
P2, N=0, Withdrawn, Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Recruiting --> Active, not recruiting N=150 --> 0
- pioglitazone / Generic mfg.
New P4 trial: Effects of Pioglitazone in Hypertensive Patients (clinicaltrials.gov) - Nov 14, 2011
P4, N=16, Completed, Sponsor: Tottori University Hospital
- azemiglitazone (MSDC-0602K) / Cirius Therap
Trial completion: A Randomized, Double-Blind, Comparator- and Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-0602 in Type 2 Diabetic Patients (clinicaltrials.gov) - Nov 3, 2011
P2, N=129, Completed, Sponsor: Metabolic Solutions Development Company
N=150 --> 0 Active, not recruiting --> Completed
- pioglitazone / Generic mfg.
Trial completion: Influence of Pioglitazone for Renal Transplant Function in Diabetics (clinicaltrials.gov) - Oct 26, 2011
P3, N=0, Completed, Sponsor: Technische Universit
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||| pioglitazone / Generic mfg.
New P1 trial: Study to Assess the Effects of Daily Administration of Pioglitazone on Brain Hemodynamics in Healthy Elderly Participants (clinicaltrials.gov) - Oct 18, 2011
P1, N=61, Completed, Sponsor: Takeda
- pioglitazone / Generic mfg.
New P1 trial: Transplantation of Autologous Mesenchymal Stem Cell in Decompensate Cirrhotic Patients With Pioglitazone (clinicaltrials.gov) - Oct 17, 2011
P1, N=3, Recruiting, Sponsor: Royan Institute
- pioglitazone / Generic mfg.
Enrollment change: Pioglitazone Before Peginterferon and Ribavirin for Hepatitis C Infection in HIV/HCV-Coinfected Patients With Insulin Resistance (clinicaltrials.gov) - Oct 5, 2011
P2, N=19, Completed, Sponsor: AIDS Clinical Trials Group
Active, not recruiting --> Completed N=30 --> 19
- pioglitazone / Generic mfg.
Enrollment closed: PEGLIST C: Pioglitazone vs. Placebo in Association With Pegylated Interferon and Ribavirin in HCV Patients With Insulin Resistance (clinicaltrials.gov) - Sep 13, 2011
P3, N=40, Active, not recruiting, Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
N=30 --> 19 Recruiting --> Active, not recruiting
- Byetta (exenatide) / AstraZeneca
New P4 trial: Effect Of Exenatide Treatment on Liver Fat Content in Patients With Diabetes (clinicaltrials.gov) - Sep 8, 2011
P4, N=24, Completed, Sponsor: Baylor College of Medicine
- MK-4074 / Merck (MSD)
New P1 trial: Study of Changes in Hepatic Fat Following Administration of MK-4074 and Pioglitazone Hydrochloride (MK-4074-008) (clinicaltrials.gov) - Sep 7, 2011
P1, N=31, Completed, Sponsor: Merck
- pioglitazone / Generic mfg.
Enrollment change: University of Texas H.S.C. San Antonio Pioglitazone in Non-Alcoholic Steatohepatitis Trial (UTHSCSA NASH Trial) (clinicaltrials.gov) - Aug 31, 2011
P4, N=90, Active, not recruiting, Sponsor: The University of Texas Health Science Center at San Antonio
Recruiting --> Active, not recruiting N=120 --> 90
- ||||||| Tenelia (teneligliptin) / Daiichi Sankyo, Mitsubishi Tanabe
Trial completion, Combination therapy: Efficacy and Safety Study of MP-513 in Combination With Thiazolidinedione in Patients With Type 2 Diabetes (clinicaltrials.gov) - Aug 25, 2011
P3, N=204, Completed, Sponsor: Mitsubishi Tanabe Pharma Corporation
N=120 --> 90 Active, not recruiting --> Completed
- pioglitazone / Generic mfg.
Enrollment change: Pioglitazone on Viral Kinetics, Cytokines and Innate Immunity in Insulin Resistant CHC GT 1 Subjects (clinicaltrials.gov) - Aug 15, 2011
P=N/A, N=23, Completed, Sponsor: Brooke Army Medical Center
Active, not recruiting --> Completed N=60 --> 23
- pioglitazone / Generic mfg.
Trial completion: Pioglitazone on Viral Kinetics, Cytokines and Innate Immunity in Insulin Resistant CHC GT 1 Subjects (clinicaltrials.gov) - Aug 15, 2011
P=N/A, N=23, Completed, Sponsor: Brooke Army Medical Center
N=60 --> 23 Recruiting --> Completed